Related Experiment Video

Updated: May 31, 2025

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

7.7K

Perspectives in MicroRNA Therapeutics for Cystic Fibrosis

Alessia Finotti1,2, Roberto Gambari1,2

  • 1Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, 44121 Ferrara, Italy.

Non-Coding RNA
|January 23, 2025
PubMed

Insights

MicroRNAs (miRNAs) show promise for cystic fibrosis (CF) therapy. This review evaluates miRNAs targeting CFTR, inflammation, and bacteria, suggesting antagomiRs and agomiRs for pre-clinical validation.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are increasingly recognized for their role in cystic fibrosis (CF).
  • Their potential as a novel therapeutic strategy in pre-clinical settings is under investigation.
  • Existing research explores miRNAs' influence on CF pathogenesis.

Purpose of the Study:

  • To review and evaluate laboratory findings relevant to miRNA-based therapeutic protocols for CF.
  • To assess miRNAs involved in CFTR upregulation, inflammation inhibition, and antibacterial activity.
  • To propose antagomiRs and agomiRs for pre-clinical validation in CF therapy.

Main Methods:

  • Narrative review of published laboratory information.
  • Comparative evaluation of studies on miRNA involvement in CF.
  • Focus on miRNAs targeting CFTR, inflammation, and bacterial infections.

Main Results:

  • Identified miRNAs that upregulate the cystic fibrosis transmembrane conductance regulator (CFTR).
  • Reviewed miRNAs with anti-inflammatory properties relevant to CF.
  • Examined miRNAs exhibiting direct antibacterial activity.
  • Highlighted the potential of antagomiRs and agomiRs (miRNA mimics).

Conclusions:

  • miRNAs represent a promising avenue for novel cystic fibrosis therapeutics.
  • AntagomiRs and agomiRs warrant further investigation in pre-clinical CF models.
  • miRNA-based therapies could offer a new class of treatments for cystic fibrosis.
Keywords:
CFTRbacterial infectioncystic fibrosisinflammationmiRNA therapeuticsmicroRNAs

More Related Videos

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

19.2K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
139
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
184
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K